Friday, 10 July 2026
Subscribe free
The independent voice of UK resident doctors165 conferences · 6 journals 55 societies · 235+ resources

MedicMess

Conferences · Journals · Societies · Research, for UK resident doctors

Home›Conferences›Thoracic Oncology›European Lung Cancer Congress 2027
Thoracic Oncology · Annual Conference

European Lung Cancer Congress 2027

Organised by the European Society for Medical Oncology
Dates17–20 Mar 2027
CityMunich, Germany
FormatIn-person + Hybrid
European Lung Cancer Congress 2027 is scheduled for Munich, Germany, from 17 to 20 March 2027, with onsite and online participation indicated.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 10 Jul 2026
MedicMess Conference Intelligence
Audience
Multidisciplinary lung cancer and thoracic oncology clinicians and researchers.
Why This Conference Matters
Networking
Specialist lung cancer congress with multidisciplinary and international audience.
Research Value
The congress is a specialist oncology congress; abstract and publication details were not yet confidently visible for 2027.
Trainee Relevance
Relevant for oncology and respiratory trainees interested in lung cancer, thoracic malignancy research or multidisciplinary cancer care.

MedicMess Tips

  • The page states onsite Munich and online participation.
  • Check back for abstract deadlines and registration pricing.
Key Deadlines
17 Mar 2027 · 250 days
Conference begins
Practical Information
Venue DetailsMunich, Germany; venue not confidently visible in the extracted page payload.
Conference Snapshot
SpecialtyThoracic Oncology
Organising societyEuropean Society for Medical Oncology
Conference formatIn-person + Hybrid
The Complete Guide to the European Lung Cancer Congress 2027

European Lung Cancer Congress 2027 is listed by ESMO as taking place onsite in Munich, Germany, and online from 17 to 20 March 2027. The source describes the congress as a collaborative multidisciplinary lung cancer meeting, which makes it relevant to oncology, respiratory, radiology, pathology and surgical trainees with an interest in thoracic malignancy. From a UK junior doctor perspective, the strongest value is likely for oncology trainees, respiratory trainees with lung cancer interests, academic trainees and doctors preparing cancer audit or research work. The current page confirms dates, city and hybrid delivery, but abstract deadlines, registration pricing, CPD/CME points and publication outcomes were not confidently visible in this scrape and should be revisited once the 2027 page is fuller.